Targeted Therapy Directed by Genetic Testing in Treating Patients With Advanced Refractory Solid Tumors, Lymphomas, or Multiple Myeloma (The MATCH Screening Trial)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Travera Inc
Seagen Inc.
National Institutes of Health Clinical Center (CC)
UNC Lineberger Comprehensive Cancer Center
AstraZeneca
Memorial Sloan Kettering Cancer Center
Bristol-Myers Squibb